Lei Li

Lei Li

Auto-generated profile, based on publicly available information

Lei Li

Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZCZhe Chen
Zhe Chen
DHDawei Huo
Dawei Huo
LLLei Li
Lei Li
ZLZhilong Liu
Zhilong Liu
ZLZhigang Li
Zhigang Li
YHYu Hou
Yu Hou
The oncogene DEK is found fused with the NUP214 gene creating oncoprotein DEK-NUP214 that induces acute myeloid leukemia (AML) in patients, and secreted DEK protein functions as a hematopoietic cytokine to regulate hematopoiesis; however, the intrinsic role of nuclear DEK in hematopoietic stem cells (HSCs) remains largely unknown. Here, we show that HSCs lacking DEK display defects in long-term self-renew capacity, eventually resulting in impaired hematopoiesis. DEK deficiency reduces quiescence and accelerates mitochondrial metabolism in HSCs, in part, dependent upon activating mTOR signaling. At the molecular level, DEK recruits the corepressor NCoR1 to repress acetylation of histone 3 at lysine 27 (H3K27ac) and restricts the chromatin accessibility of HSCs, governing the expression of quiescence-associated genes (e.g., Akt1/2, Ccnb2, and p21). Inhibition of mTOR activity largely restores the maintenance and potential of Dek-cKO HSCs. These findings highlight the crucial role of nuclear DEK in preserving HSC potential, uncovering a new link between chromatin remodelers and HSC homeostasis, and have clinical implications.

7 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
LLLei Li
Lei Li
YLYufei Lei
Yufei Lei
YLYan Li
Yan Li
YXYuxin Xie
Yuxin Xie
PHPusheng Hui
Pusheng Hui
YHYu Hou
Yu Hou
The long-term maintenance of hematopoietic stem cells (HSCs) relies on the regulation of endoplasmic reticulum (ER) stress at a low level, but the underlying mechanism remains poorly understood. Here, we demonstrate that suppression of ER stress improves the functions of HSCs and protects HSCs against ionizing radiation (IR)-induced injury. We identify epithelial membrane protein 1 (EMP1) as a key regulator that mitigates ER stress in HSCs. Emp1 deficiency leads to the accumulation of protein aggregates and elevated ER stress, ultimately resulting in impaired HSC maintenance and self-renewal. Mechanistically, EMP1 is located within the ER and interacts with ceramide synthase 2 (CERS2) to limit the production of a class of sphingolipids, dihydroceramides (dhCers). DhCers accumulate in Emp1-deficient HSCs and induce protein aggregation. Furthermore, Emp1 deficiency renders HSCs more susceptible to IR, while overexpression of Emp1 or inhibition of CERS2 protects HSCs against IR-induced injury. These findings highlight the critical role played by the EMP1-CERS2-dhCers axis in constraining ER stress and preserving HSC potential.

21 January 2025 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
ZCZhe Chen
Zhe Chen
FWFeng Wu
Feng Wu
YLYan Li
Yan Li
LLLei Li
Lei Li
YLYufei Lei
Yufei Lei
YHYu Hou
Yu Hou
Hematopoietic stem cells (HSCs) are susceptible to replication stress, which is a major contributor to HSC defects in Fanconi anemia (FA). Here, we report that HSCs relax the global chromatin by downregulating the expression of a chromatin architectural protein, DEK, in response to replication stress. DEK is abnormally accumulated in bone marrow (BM) CD34+ cells from patients with FA and in Fancd2-deficient HSCs. DEK haploinsufficiency promotes chromatin relaxation, replication stress relief, and function recovery of Fancd2-deficient HSCs. Furthermore, inhibition of DEK restores the proliferation of FA CD34+ cells in vitro and enhances their engraftment in vivo. Mechanistically, the activating transcription factor 2 (ATF2), specifically phosphorylated ATF2 at Thr69/71, was identified as a promoter of DEK transcription. Fancd2 deficiency results in p38 hyperphosphorylation, which in turn phosphorylates ATF2 at Thr69/71, leading to DEK accumulation in HSCs. In conclusion, our findings establish a functional link between chromatin relaxation and replication stress tolerance in HSCs and highlight DEK as a target for FA.

25 October 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
JWJianming Wang
Jianming Wang
QGQiang Gong
Qiang Gong
YFYinghao Fu
Yinghao Fu
YLYijia Liu
Yijia Liu
YLYu Luo
Yu Luo
XZXueya Zhao
Xueya Zhao
Leukemia stem cells (LSCs) primarily rely on mitochondrial oxidative phosphorylation (OXPHOS) for energy production, a metabolic feature that inevitably generates excessive reactive oxygen species (ROS). NYNRIN (NYN domain and retroviral integrase containing) is highly expressed in LSC-like cells and is associated with poor prognosis in patients with acute myeloid leukemia (AML). Genetic targeting of NYNRIN impairs LSC-like cell maintenance and in vivo leukemogenic capacity in MLL-AF9- and HOXA9/MEIS1-driven AML models, and compromises the in vivo pathogenicity of patient-derived LSC-like cells. Mechanistically, NYNRIN sustains thioredoxin (Trx) activity by functioning as an RNA-binding protein that directly binds and degrades TXNIP mRNA via its NYN domain. Loss of NYNRIN stabilizes TXNIP mRNA, leading to TXNIP accumulation, which disrupts Trx-mediated redox buffering, induces ROS overproduction and mitochondrial dysfunction, and triggers LSC apoptosis. Notably, NYNRIN inhibition potentiates venetoclax efficacy by compromising Trx-mediated ROS clearance, lowering the apoptotic threshold of LSCs. Collectively, our findings reveal a critical NYNRIN-TXNIP-Trx axis that safeguards LSCs by enabling efficient ROS clearance.